Oxidative stress and antioxidants in the pathophysiology of malignant melanoma
Open accessThe DOI matches its Crossref record; 233 of the 233 references it cites were found in a registry or an index.
Abstract
The high number of somatic mutations in the melanoma genome associated with cumulative ultra violet (UV) exposure has rendered it one of the most difficult of cancers to treat. With new treatment approaches based on targeted and immune therapies, drug resistance has appeared as a consistent problem. Redox biology, including reactive oxygen and nitrogen species (ROS and RNS), plays a central role in all aspects of melanoma pathophysiology, from initiation to progression and to metastatic cells. The involvement of melanin production and UV radiation in ROS/RNS generation has rendered the melanocytic lineage a unique system for studying redox biology. Overall, an elevated oxidative status has been associated with melanoma, thus much effort has been expended to prevent or treat melanoma using antioxidants which are expected to counteract oxidative stress. The consequence of this redox-rebalance seems to be two-fold: on the one hand, cells may behave less aggressively or even undergo apoptosis; on the other hand, cells may survive better after being disseminated into the circulating system or after drug treatment, thus resulting in metastasis promotion or further drug resistance. In this review we summarize the current understanding of redox signaling in melanoma at cellular and systemic levels and discuss the experimental and potential clinic use of antioxidants and new epigenetic redox modifiers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is overwhelming evidence that oxidative stress plays a central role in the different stages of melanomagenesis [ 72 , 73 ].”
Citations
Cites
1 retracted
Vaccaro, M., Irrera, N., Cutroneo, G., Rizzo, G., Vaccaro, F., Anastasi, G., Borgia, F., Cannavò, S. P., Altavilla, D., & Squadrito, F. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122533 · Cited by 33
RetractedSignatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660 · cited 1×
“Melanomas carry the largest average number of mutations among all tumors (Alexandrov et al., 2013), which has rendered melanoma a successful target for immune therapy in general.”
Background(1994) · New England Journal of Medicine · doi:10.1056/nejm199404143301501 · Cited by 4,737
Oxidative stress: oxidants and antioxidants
Sies, H. (1997) · Experimental Physiology · doi:10.1113/expphysiol.1997.sp004024 · Cited by 4,566
Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling
Ray, P. D., Huang, B.-W., & Tsuji, Y. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.01.008 · Cited by 4,373 · cited 1×
“Oxidative stress in cells is linked to the generation of ROS, formed as natural byproducts of the normal metabolism of O2 but having key roles in cell signaling and homeostasis (under both physiological and pathophysiological conditions) (Ray et al., 2012) (Figure 1).”
BackgroundSies, H., Berndt, C., & Jones, D. P. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-045037 · Cited by 3,520 · cited 4×
“The chemical reactivity of the many different reactive species may vary by up to 11 orders of magnitude when assayed against a given target [with comparable rate constants of 7 × 109 l × mol−1 × s−1 for hydroxyl radicals (HO˙) versus 2 × 10−2 l × mol−1 × s−1 for H2O2] (Sies et al., 2017).”
BackgroundInfluentialReactive oxygen species in cancer
Liou, G.-Y., & Storz, P. (2010) · Free Radical Research · doi:10.3109/10715761003667554 · Cited by 3,382
Nitric oxide: an endogenous modulator of leukocyte adhesion.
Kubes, P., Suzuki, M., & Granger, D. N. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4651 · Cited by 3,029
Production of large amounts of hydrogen peroxide by human tumor cells.
Szatrowski, T. P., & Nathan, C. (1991) · PubMed · Cited by 3,007
Reactive Species and Antioxidants. Redox Biology Is a Fundamental Theme of Aerobic Life
Halliwell, B. (2006) · Plant Physiology · doi:10.1104/pp.106.077073 · Cited by 2,394
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
DeNicola, G. M., Karreth, F. A., Humpton, T. J., Gopinathan, A., Wei, C., Frese, K., Mangal, D., Yu, K. H., Yeo, C. J., Calhoun, E. S., et al. (2011) · Nature · doi:10.1038/nature10189 · Cited by 2,277 · cited 1×
“Molecular and cellular studies revealed the master redox regulator Nrf2, may even promote tumorigenesis through detoxifying ROS (DeNicola et al., 2011).”
BackgroundThe thioredoxin antioxidant system
Lu, J., & Holmgren, A. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.07.036 · Cited by 2,055 · cited 1×
“Moreover, the NADPH-dependent thioredoxin reductase (TR)/thioredoxin (TRX) system catalyzes disulfide bond reduction in the cytoplasm and mitochondrion, therefore contributing to preserve cellular thiol homeostasis (Lu and Holmgren, 2014).”
BackgroundThe tumor microenvironment at a glance
Balkwill, F. R., Capasso, M., & Hagemann, T. (2012) · Journal of Cell Science · doi:10.1242/jcs.116392 · Cited by 1,857
Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?
Sabharwal, S. S., & Schumacker, P. T. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3803 · Cited by 1,622
Specific Aquaporins Facilitate the Diffusion of Hydrogen Peroxide across Membranes
Bienert, G. P., Møller, A. L. B., Kristiansen, K. A., Schulz, A., Møller, I. M., Schjoerring, J. K., & Jahn, T. P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m603761200 · Cited by 1,306
Oxidative stress inhibits distant metastasis by human melanoma cells
Piskounova, E., Agathocleous, M., Murphy, M. M., Hu, Z., Huddlestun, S. E., Zhao, Z., Leitch, A. M., Johnson, T. M., DeBerardinis, R. J., & Morrison, S. J. (2015) · Nature · doi:10.1038/nature15726 · Cited by 1,269
Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Valanis, B., Williams, J. H., et al. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.21.1550 · Cited by 1,255 · cited 3×
“Another human trial similarly observed that high doses of beta carotene and retinol increased lung cancer risk by 28% in smokers and workers exposed to asbestos (Omenn et al., 1996).”
BackgroundResultInfluentialSelf-citationTargeted agents and immunotherapies: optimizing outcomes in melanoma
Luke, J. J., Flaherty, K. T., Ribas, A., & Long, G. V. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.43 · Cited by 1,254
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
Krauthammer, M., Kong, Y., Ha, B. H., Evans, P., Bacchiocchi, A., McCusker, J. P., Cheng, E., Davis, M. J., Goh, G., Choi, M., et al. (2012) · Nature Genetics · doi:10.1038/ng.2359 · Cited by 1,191 · cited 1×
“While RAC1 itself is a melanoma oncogene (Krauthammer et al., 2012), it is also an activator for NOX1 and is potentially associated with elevated cellular ROS levels (Cheng et al.”
BackgroundSuperoxide and hydrogen peroxide in relation to mammalian cell proliferation
Burdon, R. H. (1995) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(94)00198-s · Cited by 1,173
Role of interleukin-6 in cancer progression and therapeutic resistance
Kumari, N., Dwarakanath, B. S., Das, A., & Bhatt, A. N. (2016) · Tumor Biology · doi:10.1007/s13277-016-5098-7 · Cited by 1,092
Membrane transport of hydrogen peroxide
Bienert, G. P., Schjoerring, J. K., & Jahn, T. P. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.02.015 · Cited by 1,075
Glutathione in Cancer Biology and Therapy
Estrela, J. M., Ortega, A., & Obrador, E. (2006) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360500523878 · Cited by 1,041
Self-citationRedox- and non-redox-metal-induced formation of free radicals and their role in human disease
Valko, M., Jomova, K., Rhodes, C. J., Kuča, K., & Musílek, K. (2016) · Archives of Toxicology · doi:10.1007/s00204-015-1579-5 · Cited by 1,022
Oxidative Stress, Antioxidant Defenses, and Damage Removal, Repair, and Replacement Systems
Davies, K. J. A. (2000) · IUBMB Life · doi:10.1080/15216540051081010 · Cited by 926
Meister, A. (1991) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(91)90076-x · Cited by 907
Shain, A. H., & Bastian, B. C. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.37 · Cited by 896
Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function
Hu, W., Zhang, C., Wu, R., Sun, Y., Levine, A., & Feng, Z. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001006107 · Cited by 862
Oncogenic BRAF Regulates Oxidative Metabolism via PGC1α and MITF
Haq, R., Shoag, J., Andreu-Perez, P., Yokoyama, S., Edelman, H., Rowe, G. C., Frederick, D. T., Hurley, A. D., Nellore, A., Kung, A. L., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.02.003 · Cited by 818 · cited 2×
“Interestingly, BRAF regulates oxidative metabolism via PGC1alpha and MITF (Haq et al., 2013), and PGC1alpha expression in particular has been linked to increased mitochondrial capacity and resistance to oxidative stress in melanoma (Vazquez et al., 2013).”
BackgroundKim, H.-S., Quon, M. J., & Kim, J.-A. (2014) · Redox Biology · doi:10.1016/j.redox.2013.12.022 · Cited by 804
Vazquez, F., Lim, J.-H., Chim, H., Bhalla, K., Girnun, G., Pierce, K., Clish, C. B., Granter, S. R., Widlund, H. R., Spiegelman, B. M., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2012.11.020 · Cited by 715
Cameron, E., & Pauling, L. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.10.3685 · Cited by 710
Nitric oxide metabolism and breakdown
Kelm, M. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(99)00020-1 · Cited by 673 · cited 1×
“The interactions between T cells and tumor cells are mediated by ligands and receptors, and modulated by many factors from the tumor microenvironment including NO, which is often locally produced and consumed due to their short living time and travel distance (Kelm, 1999).”
BackgroundSelenium for preventing cancer
Vinceti, M., Filippini, T., Del Giovane, C., Dennert, G., Zwahlen, M., Brinkman, M., Zeegers, M. P., Horneber, M., D'Amico, R., & Crespi, C. M. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005195.pub4 · Cited by 649
Jones, D. P., & Sies, H. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6247 · Cited by 647 · cited 2×
“lactate and pyruvate, β-hydroxybutyrate, and acetoacetate), whose interconversion is dependent on these ratio (Krebs and Veech, 1969; Bücher et al., 1972; Schönfeld et al., 1983; Sies et al., 1983; Jones and Sies, 2015).”
BackgroundNitric oxide and cancer: a review
Korde Choudhari, S., Chaudhary, M., Bagde, S., Gadbail, A. R., & Joshi, V. (2013) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-11-118 · Cited by 634
Antioxidants can increase melanoma metastasis in mice
Le Gal, K., Ibrahim, M. X., Wiel, C., Sayin, V. I., Akula, M. K., Karlsson, C., Dalin, M. G., Akyürek, L. M., Lindahl, P., Nilsson, J., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aad3740 · Cited by 632 · cited 1×
“Additionally, NAC-treated mice exhibited higher intratumoral GSH levels (Le Gal et al., 2015).”
BackgroundHalestrap, A. P., Woodfield, K.-Y., & Connern, C. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3346 · Cited by 590
Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF V600E melanoma
Hu-Lieskovan, S., Mok, S., Homet Moreno, B., Tsoi, J., Robert, L., Goedert, L., Pinheiro, E. M., Koya, R. C., Graeber, T. G., Comin-Anduix, B., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa4691 · Cited by 563
Oxidative stress: damage to intact cells and organs
Sies, H., & Cadenas, E. (1985) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1985.0168 · Cited by 551
ROS in Cancer: The Burning Question
Chio, I. I. C., & Tuveson, D. A. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.03.004 · Cited by 532
Impact of Stress on Cancer Metastasis
Moreno-Smith, M., Lutgendorf, S. K., & Sood, A. K. (2010) · Future Oncology · doi:10.2217/fon.10.142 · Cited by 510
Cameron, E., & Pauling, L. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.9.4538 · Cited by 476
Church, S. L., Grant, J. W., Ridnour, L. A., Oberley, L. W., Swanson, P. E., Meltzer, P. S., & Trent, J. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.7.3113 · Cited by 473
Role of oxidative stress and the antioxidant network in cutaneous carcinogenesis
Sander, C. S., Chang, H., Hamm, F., Elsner, P., & Thiele, J. J. (2004) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2004.02222.x · Cited by 438
Melanocytes as Instigators and Victims of Oxidative Stress
Denat, L., Kadekaro, A. L., Marrot, L., Leachman, S. A., & Abdel-Malek, Z. A. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.65 · Cited by 416
Disposition of quercetin in man after single oral and intravenous doses
Gugler, R., Leschik, M., & Dengler, H. J. (1975) · European Journal of Clinical Pharmacology · doi:10.1007/bf00614022 · Cited by 404
Bethin, K. E., Vogt, S. K., & Muglia, L. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.9317 · Cited by 381 · cited 1×
“IL-6, in particular, is a corticotropin releasing hormone (CRH)-independent stimulator of the pituitary-adrenal axis (Bethin et al., 2000).”
BackgroundThe Role of Chemokines in Melanoma Tumor Growth and Metastasis
Payne, A. S., & Cornelius, L. A. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01725.x · Cited by 361
Hirose, K., Longo, D. L., Oppenheim, J. J., & Matsushima, K. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.2.8440412 · Cited by 340
Selenium: a double-edged sword for defense and offence in cancer
Brozmanová, J., Mániková, D., Vlčková, V., & Chovanec, M. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0595-8 · Cited by 333
An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential
Wang, L., Leite de Oliveira, R., Huijberts, S., Bosdriesz, E., Pencheva, N., Brunen, D., Bosma, A., Song, J.-Y., Zevenhoven, J., Los-de Vries, G. T., et al. (2018) · Cell · doi:10.1016/j.cell.2018.04.012 · Cited by 327
Yang, E. V., Kim, S.-J., Donovan, E. L., Chen, M., Gross, A. C., Webster Marketon, J. I., Barsky, S. H., & Glaser, R. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.10.005 · Cited by 317
Cytokines as modulators of the hypothalamus-pituitary-adrenal axis
Besedovsky, H. O., Del Rey, A., Klusman, I., Furukawa, H., Monge Arditi, G., & Kabiersch, A. (1991) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(91)90284-c · Cited by 314
Oxidative stress in malignant melanoma and non-melanoma skin cancer
Sander, C. S., Hamm, F., Elsner, P., & Thiele, J. J. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05303.x · Cited by 300
Cellular reducing equivalents and oxidative stress
Kehrer, J. P., & Lund, L. G. (1994) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(94)90008-6 · Cited by 282
Allen, J. F. (1993) · Journal of Theoretical Biology · doi:10.1006/jtbi.1993.1210 · Cited by 279
Nox1-dependent Reactive Oxygen Generation Is Regulated by Rac1
Cheng, G., Diebold, B. A., Hughes, Y., & Lambeth, J. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512751200 · Cited by 277
Overexpression of Akt converts radial growth melanoma to vertical growth melanoma
Govindarajan, B., Sligh, J. E., Vincent, B. J., Li, M., Canter, J. A., Nickoloff, B. J., Rodenburg, R. J., Smeitink, J. A., Oberley, L., Zhang, Y., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30102 · Cited by 270
Cancer, Oxidative Stress, and Metastasis
Gill, J. G., Piskounova, E., & Morrison, S. J. (2016) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2016.81.030791 · Cited by 266
Saw, C. L. L., Guo, Y., Yang, A. Y., Paredes-Gonzalez, X., Ramirez, C., Pung, D., & Kong, A.-N. T. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2014.07.038 · Cited by 261
Li, D., Ueta, E., Kimura, T., Yamamoto, T., & Osaki, T. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03323.x · Cited by 255
Stafford, W. C., Peng, X., Olofsson, M. H., Zhang, X., Luci, D. K., Lu, L., Cheng, Q., Trésaugues, L., Dexheimer, T. S., Coussens, N. P., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf7444 · Cited by 240
Reactive carbonyls and oxidative stress: Potential for therapeutic intervention
Ellis, E. M. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.03.015 · Cited by 236
Induction of mitochondrial manganese superoxide dismutase by interleukin 1
Masuda, A., Longo, D. L., Kobayashi, Y., Appella, E., Oppenheim, J. J., & Matsushima, K. (1988) · The FASEB Journal · doi:10.1096/fasebj.2.15.3263930 · Cited by 227
Diagnostic and prognostic biomarkers in melanoma.
Weinstein, D. M., Leininger, J., Hamby, C. V., & Safai, B. (2014) · PubMed · Cited by 222
Use of Antioxidants During Chemotherapy and Radiotherapy Should Be Avoided
D'Andrea, G. M. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.5.319 · Cited by 217
Ekmekçioglu, S., Ellerhorst, J. A., Smid, C. M., Prieto, V. G., Munsell, M. F., Buzaid, A. C., & Grimm, E. A. (2000) · PubMed · Cited by 214
Direct Activation of RhoA by Reactive Oxygen Species Requires a Redox-Sensitive Motif
Aghajanian, A., Wittchen, E. S., Campbell, S. L., & Burridge, K. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008045 · Cited by 208
Chiou, Y.-S., Tsai, M.-L., Nagabhushanam, K., Wang, Y.-J., Wu, C.-H., Ho, C.-T., & Pan, M.-H. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf2000103 · Cited by 205
The role of peroxiredoxins in cancer
Nicolussi, A., D'Inzeo, S., Capalbo, C., Giannini, G., & Coppa, A. (2017) · Molecular and Clinical Oncology · doi:10.3892/mco.2017.1129 · Cited by 200
Yamaura, M., Mitsushita, J., Furuta, S., Kiniwa, Y., Ashida, A., Goto, Y., Shang, W. H., Kubodera, M., Kato, M., Takata, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3745 · Cited by 187
Glutamine Transport and Mitochondrial Metabolism in Cancer Cell Growth
Scalise, M., Pochini, L., Galluccio, M., Console, L., & Indiveri, C. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00306 · Cited by 183 · cited 1×
“…(a) increased mitochondrial glutaminase 2 activity that is dependent on Rho GTPases and NF-kB activity; and (b) oncogenic levels of Myc which induce a transcriptional program that promotes glutaminolysis and trigger cellular addiction to L-Gln as a bioenergetic substrate (Scalise et al., 2017).”
BackgroundLiu, Q., Chen, F., Hou, L., Shen, L., Zhang, X., Wang, D., & Huang, L. (2018) · ACS Nano · doi:10.1021/acsnano.8b01890 · Cited by 183
Selenium for preventing cancer
Vinceti, M., Dennert, G., Crespi, C. M., Zwahlen, M., Brinkman, M. T., Zeegers, M. P., Horneber, M., D’Amico, R., & Giovane, C. D. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005195.pub3 · Cited by 183
Hirose, M. (1998) · Carcinogenesis · doi:10.1093/carcin/19.1.207 · Cited by 180
Asensi, M., Sastre, J., Pallardo, F. V., Delaasuncion, J. G., Estrela, J. M., & Vina, J. (1994) · Analytical Biochemistry · doi:10.1006/abio.1994.1126 · Cited by 179
Self-citationMelanoma treatment: from conventional to nanotechnology
Mishra, H., Mishra, P. K., Ekielski, A., Jaggi, M., Iqbal, Z., & Talegaonkar, S. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2726-1 · Cited by 179
Kruk, J., & Aboul-Enein, H. Y. (2017) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557517666170228115324 · Cited by 178
Syed, D. N., Afaq, F., Maddodi, N., Johnson, J. J., Sarfaraz, S., Ahmad, A., Setaluri, V., & Mukhtar, H. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.6 · Cited by 171
Role of reactive oxygen species in cell toxicity
Sies, H., & de Groot, H. (1992) · Toxicology Letters · doi:10.1016/0378-4274(92)90230-h · Cited by 171
Li, W., Ma, J., Ma, Q., Li, B., Han, L., Liu, J., Xu, Q., Duan, W., Yu, S., Wang, F., et al. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990251 · Cited by 171
Krebs, H. A., & Veech, R. L. (1969) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(69)90030-2 · Cited by 169
Metabolomic alterations in human cancer cells by vitamin C-induced oxidative stress
Uetaki, M., Tabata, S., Nakasuka, F., Soga, T., & Tomita, M. (2015) · Scientific Reports · doi:10.1038/srep13896 · Cited by 169
Comito, G., Calvani, M., Giannoni, E., Bianchini, F., Calorini, L., Torre, E., Migliore, C., Giordano, S., & Chiarugi, P. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.05.042 · Cited by 168
Cuprous oxide nanoparticles inhibit the growth and metastasis of melanoma by targeting mitochondria
Wang, Y., Yang, F., Zhang, H.-X., Zi, X.-Y., Pan, X.-H., Chen, F., Luo, W.-D., Li, J.-X., Zhu, H.-Y., & Hu, Y.-P. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.314 · Cited by 166
Bucher, T., BRAUSER, B., CONZE, A., KLEIN, F., LANGGUTH, O., & SIES, H. (1972) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1972.tb01840.x · Cited by 165
The differential role of reactive oxygen species in early and late stages of cancer
Assi, M. (2017) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00247.2017 · Cited by 158
Melanins and Melanosomes: Biosynthesis, Biogenesis, Physiological, and Pathological Functions
(2011) · Wiley eBooks · doi:10.1002/9783527636150 · Cited by 156
Reactive oxygen species in melanoma and its therapeutic implications
Wittgen, H. G. M., & van Kempen, L. C. L. T. (2007) · Melanoma Research · doi:10.1097/cmr.0b013e3282f1d312 · Cited by 156
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy
Estrela, J. M., Mena, S., Obrador, E., Benlloch, M., Castellano, G., Palmer, R. S., & Dellinger, R. W. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01026 · Cited by 152
Self-citationRedox control of cancer cell destruction
Hegedűs, C., Kovács, K. É., Polgár, Z., Regdon, Z., Szabó, É., Robaszkiewicz, A., Forman, H. J., Martner, A., & Virág, L. (2018) · Redox Biology · doi:10.1016/j.redox.2018.01.015 · Cited by 152
Nitric Oxide: The Forgotten Child of Tumor Metabolism
Rizi, B. S., Achreja, A., & Nagrath, D. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.07.005 · Cited by 150
From Melanocyte to Metastatic Malignant Melanoma
Bandarchi, B., Ma, L., Navab, R., et al. (2010) · Dermatology Research and Practice · doi:10.1155/2010/583748 · Cited by 137
Saleem, M., Maddodi, N., Zaid, M. I. A., Khan, N., Hafeez, B. B., Asim, M., Suh, Y. K., Yun, J., Setaluri, V., & Mukhtar, H. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4413 · Cited by 137
Avery‐Kiejda, K. A., Bowden, N. A., Croft, A. J., Scurr, L. L., Kairupan, C. F., Ashton, K. A., Talseth‐Palmer, B. A., Rizos, H., Zhang, X. D., Scott, R. J., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-203 · Cited by 136
Sikora, A. G., Gelbard, A. H., Davies, M. A., Sano, D., Ekmekçioglu, S., Kwon, J., Hailemichael, Y., Jayaraman, P., Myers, J. N., Grimm, E. A., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3123 · Cited by 135
Treatment of metastatic melanoma with an orally available inhibitor of the Ras-Raf-MAPK cascade.
Collisson, E. A., De, A., Suzuki, H., Gambhir, S. S., & Kolodney, M. S. (2003) · PubMed · Cited by 129
Updates of reactive oxygen species in melanoma etiology and progression
Liu, F., Dellinger, R. W., & Meyskens, F. L. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.04.007 · Cited by 127
Self-citationSildenafil Use and Increased Risk of Incident Melanoma in US Men
Li, W., Qureshi, A. A., Robinson, K. C., & Han, J. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.594 · Cited by 126
Aberrant redox regulation in human metastatic melanoma cells compared to normal melanocytes
Meyskens, F. L., McNulty, S. E., Buckmeier, J. A., Tohidian, N. B., Spillane, T. J., Kahlon, R. S., & Gonzalez, R. I. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00650-5 · Cited by 126
Self-citationCarretero, J., Obrador, E., Anasagasti, M. J., Martin, J. J., Vidal‐Vanaclocha, F., & Estrela, J. M. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1006725226078 · Cited by 125
Self-citationNew, L., & Chan, E. C. Y. (2008) · Journal of Chromatographic Science · doi:10.1093/chromsci/46.3.209 · Cited by 124
Glutamine, cancer, and its therapy
Klimberg, V., & McClellan, J. L. (1996) · The American Journal of Surgery · doi:10.1016/s0002-9610(96)00217-6 · Cited by 121
Kondoh, M., Ohga, N., Akiyama, K., Hida, Y., Maishi, N., Towfik, A. M., Inoue, N., Shindoh, M., & Hida, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080349 · Cited by 120
Xiang, L., Xie, G., Liu, C., Zhou, J., Chen, J., Yu, S., Li, J., Pang, X., Shi, H., & Liang, H. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.08.003 · Cited by 117
Glutamine‐fueled mitochondrial metabolism is decoupled from glycolysis in melanoma
Filipp, F. V., Ratnikov, B. I., Ingeniis, J. D., Smith, J. W., Osterman, A. L., & Scott, D. A. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12000 · Cited by 116
Pal, H. C., Sharma, S., Strickland, L. R., Katiyar, S. K., Ballestas, M. E., Athar, M., Elmets, C. A., & Afaq, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086338 · Cited by 113
Quercetin Increases the Severity of Estradiol-Induced Tumorigenesis in Hamster Kidney
Zhu, B. T., & Liehr, J. G. (1994) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1994.1059 · Cited by 108
Advanced Melanoma: Current Treatment Options, Biomarkers, and Future Perspectives
Rozeman, E. A., Dekker, T. J. A., Haanen, J. B. A. G., & Blank, C. U. (2017) · American Journal of Clinical Dermatology · doi:10.1007/s40257-017-0325-6 · Cited by 106
Jobe, N. P., Rösel, D., Dvořánková, B., Kodet, O., Lacina, L., Mateu, R., Smetana, K., & Brábek, J. (2016) · Histochemistry and Cell Biology · doi:10.1007/s00418-016-1433-8 · Cited by 103
Liu, F., Garcia, A., & Meyskens, F. L. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.119 · Cited by 102
Self-citationLim, J.-H., Luo, C., Vazquez, F., & Puigserver, P. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2893-t · Cited by 102
Grimm, E. A., Sikora, A. G., & Ekmekçioglu, S. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1554 · Cited by 101
The reactive oxygen‐driven tumor: relevance to melanoma
Fried, L. E., & Arbiser, J. L. (2008) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2008.00451.x · Cited by 100
Influence of Melanosome Dynamics on Melanoma Drug Sensitivity
Chen, K. G., Leapman, R. D., Zhang, G., Lai, B. C. H., Valencia, J. C., CARDARELLI, C. O., Vieira, W. D., Hearing, V. J., & Gottesman, M. M. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp259 · Cited by 99
Meyskens, F. L., Buckmeier, J. A., McNulty, S. E., & Tohidian, N. B. (1999) · PubMed · Cited by 98
Self-citationKhamari, R., Trinh, A., Gabert, P.-E., Corazao-Rozas, P., Riveros-Cruz, S., Balayssac, S., Malet‐Martino, M., Dekiouk, S., Curt, M. J.-C., Maboudou, P., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0340-4 · Cited by 97
Gu, Z., Wang, Q., Shi, Y., Huang, Y., Zhang, J., Zhang, X., & Lin, G. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.08.011 · Cited by 96
Melanosome degradation: Fact or fiction
Borovanský, J., & Elleder, M. (2003) · Pigment Cell Research · doi:10.1034/j.1600-0749.2003.00040.x · Cited by 94 · cited 2×
“In contrast, our understanding of melanosomal degradation remains limited, although it is better understood than it was just 15 years ago, when the very phenomenon of melanosome degradation was questioned (Borovanský and Elleder, 2003).”
BackgroundPal, H. C., Baxter, R. D., Hunt, K. M., Agarwal, J., Elmets, C. A., Athar, M., & Afaq, F. (2015) · Oncotarget · doi:10.18632/oncotarget.5064 · Cited by 93
Reactive oxygen species: an Achilles’ heel of melanoma?
Fruehauf, J. P., & Trapp, V. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.11.1751 · Cited by 92
Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma
Loeb, S., Folkvaljon, Y., Lambe, M. P., et al. (2015) · JAMA · doi:10.1001/jama.2015.6604 · Cited by 91
Oxidative Stress and Antioxidants in Carcinogenesis and Integrative Therapy of Cancer
Milković, L., Siems, W., Siems, R., et al. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140826152822 · Cited by 88
Obrador, E., Carretero, J., Ortega, A., Medina, I., Rodilla, V., Pellicer, J. A., & Estrela, J. M. (2002) · Hepatology · doi:10.1053/jhep.2002.30277 · Cited by 87
Self-citationHydrogen Peroxide as an Inducer of Elevated Tyrosinase Level in Melanoma Cells
Karg, E., Odh, G., Wittbjer, A., Rosengren, E., & Rorsman, H. (1993) · Journal of Investigative Dermatology · doi:10.1038/jid.1993.78 · Cited by 87
Specific targeting of Wnt/ -catenin signaling in human melanoma cells by a dietary triterpene lupeol
Tarapore, R. S., Siddiqui, I. A., Saleem, M., Adhami, V. M., Spiegelman, V. S., & Mukhtar, H. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq169 · Cited by 86
Reich, R., & Martin, G. R. (1996) · Prostaglandins · doi:10.1016/0090-6980(95)00154-9 · Cited by 85
Role of Melanin in Melanocyte Dysregulation of Reactive Oxygen Species
Jenkins, N., & Grossman, D. (2013) · BioMed Research International · doi:10.1155/2013/908797 · Cited by 85
The Quest for Selective Nox Inhibitors and Therapeutics: Challenges, Triumphs and Pitfalls
Cifuentes-Pagano, E., Meijles, D. N., & Pagano, P. J. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5620 · Cited by 84
Disturbed melanin synthesis and chronic oxidative stress in dysplastic naevi
Pavel, S., van Nieuwpoort, F., van der Meulen, H., Out, C., Pizinger, K., Cetkovská, P., Smit, N. P. M., & Koerten, H. K. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.11.035 · Cited by 84 · cited 1×
“Increased phaeomelanogenesis in dysplastic naevi cells (a known risk factor for malignant melanoma) is connected with oxidative imbalance, which is reflected by increased intracellular concentrations of ROS and raised calcium and iron concentrations (Pavel et al., 2004).”
BackgroundMcNulty, S. E., Rosario, R. D., Cen, D., Meyskens, F. L., & Yang, S. (2004) · Pigment Cell Research · doi:10.1111/j.1600-0749.2004.00128.x · Cited by 83
Self-citationThe Oxygen Paradox, the French Paradox, and age-related diseases
Davies, J. M. S., Cillard, J., Friguet, B., Cadenas, E., Cadet, J., Cayce, R., Fishmann, A., Liao, D., Bulteau, A.-L., Derbré, F., et al. (2017) · GeroScience · doi:10.1007/s11357-017-0002-y · Cited by 82 · cited 1×
“Of course, this balance depends on concentration as too high a concentration of the reactive species can be toxic (Davies et al., 2017).”
BackgroundTrisciuoglio, D., Desideri, M., Ciuffreda, L., Mottolese, M., Ribatti, D., Vacca, A., Rosso, M. D., Marcocci, L., Zupi, G., & Bufalo, D. D. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20413 · Cited by 81
Liu, F., Farhat, A. M., Arce, A., Ziogas, A., Taylor, T. H., Wang, Z., Yourk, V., Liu, J., Wu, J. Y., McEligot, A. J., et al. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.08.027 · Cited by 81
Self-citationMolecular insights into tumour metastasis: tracing the dominant events
Jin, K., Li, T., van Dam, H., Zhou, F., & Zhang, L. (2016) · The Journal of Pathology · doi:10.1002/path.4871 · Cited by 81
Oxidative stress in melanocyte senescence and melanoma transformation
Meierjohann, S. (2013) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2013.11.005 · Cited by 79
Xia, Y., Xu, T., Wang, C., Li, Y., Lin, Z., Zhao, M., & Zhu, B. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s148960 · Cited by 79
Lee, D. J., Kang, D. H., Choi, M., Choi, Y. J., Lee, J. Y., Park, J. H., Park, Y. J., Lee, K. W., & Kang, S. W. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4226 · Cited by 74
Farmer, P. J., Gidanian, S., Shahandeh, B., Bilio, A. J. D., Tohidian, N. B., & Meyskens, F. L. (2003) · Pigment Cell Research · doi:10.1034/j.1600-0749.2003.00046.x · Cited by 73
Self-citationExpression and Function of Bcl-2 Proteins in Melanoma
Eberle, J., & Hossini, A. M. (2008) · Current Genomics · doi:10.2174/138920208785699571 · Cited by 71
Hirose, M., Hoshiya, T., Mizoguchi, Y., Nakamura, A., Akagi, K., & Shirai, T. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00502-x · Cited by 70
Benlloch, M., Obrador, E., Vallés, S. L., Rodríguez, M. L., Sirerol, J. A., Alcácer, J., Pellicer, J. A., Palmer, R. S., Cerdá, C., Sáez, G. T., et al. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6437 · Cited by 69
Self-citationMeierjohann, S., Hufnagel, A., Wende, E., Kleinschmidt, M. A., Wolf, K., Friedl, P., Gaubatz, S., & Schartl, M. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-201 · Cited by 68
Gidanian, S., Mentelle, M., Meyskens, F. L., & Farmer, P. J. (2008) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2008.00309.x · Cited by 66
Self-citationVallés, S. L., Benlloch, M., Rodríguez, M. L., Mena, S., Pellicer, J. A., Asensi, M. A., Obrador, E., & Estrela, J. M. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-72 · Cited by 66
Self-citationMelanoma metabolism contributes to the cellular responses to MAPK/ERK pathway inhibitors
Marchetti, P., Trinh, A., Khamari, R., & Kluza, J. (2018) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2018.01.018 · Cited by 66
The Role of Nitric Oxide Synthase Uncoupling in Tumor Progression
Rabender, C. S., Alam, A., Sundaresan, G., Cardnell, R. J., Yakovlev, V. A., Mukhopadhyay, N. D., Graves, P. R., Zweit, J., & Mikkelsen, R. B. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0057-t · Cited by 63
Targeting iNOS to increase efficacy of immunotherapies
Ekmekçioglu, S., Grimm, E. A., & Roszik, J. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1276682 · Cited by 63
Xia, J., Du, Y., Huang, L., Chaurasiya, B., Tu, J., Webster, T. J., & Sun, C. (2018) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2017.12.017 · Cited by 63
Nihal, M., Ahsan, H., Siddiqui, I. A., Mukhtar, H., Ahmad, N., & Wood, G. S. (2009) · Cell Cycle · doi:10.4161/cc.8.13.8862 · Cited by 62
Scheit, K., & Bauer, G. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv010 · Cited by 62
Cytokines and Growth Factors Expressed by Human Cutaneous Melanoma
Elias, E. G., Hasskamp, J. H., & Sharma, B. K. (2010) · Cancers · doi:10.3390/cancers2020794 · Cited by 60
Yang, Z., Misner, B., Ji, H., Poulos, T. L., Silverman, R. B., Meyskens, F. L., & Yang, S. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4563 · Cited by 60
Self-citationThe ultrastructure of benign pigmented naevi and melanocarcinomas in man
Curran, R. C., & McCann, B. G. (1976) · The Journal of Pathology · doi:10.1002/path.1711190303 · Cited by 60
Meyskens, F. L., CHAU, H. V., Tohidian, N. B., & Buckmeier, J. A. (1997) · Pigment Cell Research · doi:10.1111/j.1600-0749.1997.tb00482.x · Cited by 58
Self-citationProduction of superoxide by human malignant melanoma cells
Bittinger, F., Gonz??lez-Garc??a, J. L., Klein, C. L., Brochhausen, C., Offner, F. C., & Kirkpatrick, C. J. (1998) · Melanoma Research · doi:10.1097/00008390-199810000-00001 · Cited by 56
Tsai, M.-L., Lai, C., Chang, Y.-H., Chen, W. J., Ho, C., & Pan, M. (2012) · Food & Function · doi:10.1039/c2fo30105a · Cited by 55
Hsiao, P., Chou, Y., Tan, P., Lee, W.-J., Yang, S.-F., Chow, J., Chen, H.-Y., Lin, C., Lee, L.-M., & Chien, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105342 · Cited by 54
Yang, G., Yan, Y., Ma, Y., & Yang, Y. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22654 · Cited by 54
Autophagy and mitophagy interplay in melanoma progression
Maes, H., & Agostinis, P. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.07.003 · Cited by 53
Ekshyyan, O. Y., & Aw, T. Y. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401650 · Cited by 53
Yamanishi, D. T., Buckmeier, J. A., & Meyskens, F. L. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12480698 · Cited by 52
Self-citationSelenium for the Prevention of Cutaneous Melanoma
Cassidy, P. B., Fain, H. D., Cassidy, J., Tran, S., Moos, P. J., Boucher, K. M., Gerads, R., Florell, S. R., Grossman, D., & Leachman, S. A. (2013) · Nutrients · doi:10.3390/nu5030725 · Cited by 52
Regulation of glutathione metabolism in Ehrlich ascites tumour cells
Estrela, J. M., Hernandez, R., Terradez, P., Asensi, M. A., Puertes, I. R., & Viña, J. (1992) · Biochemical Journal · doi:10.1042/bj2860257 · Cited by 52
Self-citationRedox signaling regulated by electrophiles and reactive sulfur species
Nishida, M., Kumagai, Y., Ihara, H., Fujii, S., Motohashi, H., & Akaike, T. (2016) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.15-111 · Cited by 52
Comparison of the prognostic value of matrix metalloproteinases 2 and 9 in cutaneous melanoma
Väisänen, A., Kallioinen, M. J., & Turpeenniemi-Hujanen, T. M. (2008) · Human Pathology · doi:10.1016/j.humpath.2007.06.021 · Cited by 51
Rhodes, A. R., Seki, Y., Fitzpatrick, T. B., & Stern, R. S. (1988) · Cancer · doi:10.1002/1097-0142(19880115)61:2<358::aid-cncr2820610227>3.0.co;2-# · Cited by 50
Tanese, K., Grimm, E. A., & Ekmekçioglu, S. (2011) · International Journal of Cancer · doi:10.1002/ijc.26451 · Cited by 49
Ortega, Á., Ferrer, P., Carretero, J., Obrador, E., Asensi, M. A., Pellicer, J. A., & Estrela, J. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303753200 · Cited by 49
Self-citationEnergy metabolism in skin cancers: A therapeutic perspective
Hosseini, M., Kasraian, Z., & Rezvani, H. R. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.01.013 · Cited by 49
Tumoricidal Activity of Endothelial Cells
Carretero, J., Obrador, E., Esteve, J. M., Ortega, Á., Pellicer, J. A., Vera-Sempere, F. J., & Estrela, J. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101148200 · Cited by 48
Self-citationLeukotriene B4 Creates a Favorable Microenvironment for Murine Melanoma Growth
Bachi, A. L. L., Kim, F. J. K., Nonogaki, S., Carneiro, C. R. W., Lopes, J. D., Jasiulionis, M. G., & Correa, M. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0038 · Cited by 48
Goodson, A. G., Cotter, M. A., Cassidy, P. B., Wade, M. L., Florell, S. R., Liu, T., Boucher, K. M., & Grossman, D. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1890 · Cited by 48
Matthews, A., Langan, S., Douglas, I., Smeeth, L. L., & Bhaskaran, K. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1002037 · Cited by 48
Benlloch, M., Mena, S., Ferrer, P., Obrador, E., Asensi, M. A., Pellicer, J. A., Carretero, J., Ortega, Á., & Estrela, J. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507471200 · Cited by 47
Self-citationAssociation Between Oxidative Stress and Melanoma Progression
Bisevac, J. P., Djukic, M. M., Stanojević, I., Stevanović, I. D., Mijušković, Ž. P., Djurić, A., Gobeljić, B., Banovic, T., & Vojvodić, D. (2017) · Journal of Medical Biochemistry · doi:10.1515/jomb-2017-0040 · Cited by 47
Bracalente, C., Ibañez, I. L., Berenstein, A., Notcovich, C., Cerda, M. B., Klamt, F., Chernomoretz, A., & Durán, H. (2106) · Oncotarget · doi:10.18632/oncotarget.9273 · Cited by 46
Multidrug Resistance Decreases with Mutations of Melanosomal Regulatory Genes
Xie, T., Nguyen, T. N., Hupe, M., & Wei, M. L. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-0506 · Cited by 45
Schmitt, A., Schmitz, W., Hufnagel, A., Schartl, M., & Meierjohann, S. (2015) · Biochemical Journal · doi:10.1042/bj20141204 · Cited by 45
Li, H., Jiang, N., Liang, B., Liu, Q., Zhang, E., Peng, L., Deng, H., Li, R., Li, Z., & Zhu, H. (2017) · Redox Report · doi:10.1080/13510002.2017.1329917 · Cited by 45
Effect of sildenafil on skeletal and cardiac muscle in B ecker muscular dystrophy
Witting, N., Kruuse, C. R., Nyhuus, B., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24216 · Cited by 43
Age-dependent interaction between sex and geographic ultraviolet index in melanoma risk
Liu, F., & Ziogas, A. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2017.11.049 · Cited by 43
Woźniak, A., Drewa, G., Woźniak, B., & Schachtschabel, D. O. (2004) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-004-0229-y · Cited by 41
Huang, H., Li, H., Yang, S., Chreifi, G., Pavel Martasek, E., Roman, L. J., Meyskens, F. L., Poulos, T. L., & Silverman, R. B. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401252e · Cited by 41
Self-citationGlutamine potentiates TNF-α-induced tumor cytotoxicity
Obrador, E., Carretero, J., Esteve, J. M., Pellicer, J. A., Pascual, A., Petschen, I., & Estrela, J. M. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00622-0 · Cited by 39
Self-citationCellular redox changes and response to drugs and toxic agents
Sies, H., Brigelius, R., Wefers, H., et al. (1983) · Fundamental and Applied Toxicology · doi:10.1016/s0272-0590(83)80126-2 · Cited by 38
de Melo, F. H. M., Molognoni, F., Morais, A. S., Toricelli, M., Mouro, M. G., Higa, E. M. S., Lopes, J. D., & Jasiulionis, M. G. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.02.022 · Cited by 38
Suresh, A., Guedez, L., Moreb, J., & Zucali, J. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04074.x · Cited by 36
Interleukin-6-induced Twist and N-cadherin enhance melanoma cell metastasis
Na, Y., Lee, J., Lee, S.-J., & Seok, S. (2013) · Melanoma research · doi:10.1097/cmr.0000000000000021 · Cited by 36
Systemic oxidative profile after tumor removal and the tumor microenvironment in melanoma patients
Bernardes, S. S., de Souza-Neto, F. P., Ramalho, L. N. Z., Derossi, D. R., Guarnier, F. A., Silva, C. F. N., Melo, G. P., Simão, A. N. C., Cecchini, R., & Cecchini, A. L. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.03.007 · Cited by 35
Mitochondrial function in melanoma
Theodosakis, N., Micevic, G., Kelly, D. P., & Bosenberg, M. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.06.028 · Cited by 35
Redox Modulation of FAK Controls Melanoma Survival - Role of NOX4
Ribeiro-Pereira, C., Moraes, J. A., Souza, M. D. J., Laurindo, F. R., Arruda, M. A., & Barja-Fidalgo, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099481 · Cited by 35
Yu, C.-L., Yap, N. L., Chen, D., & Cheng, S.-Y. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)00186-9 · Cited by 33
Meta-Analysis of the Association Between Phosphodiesterase Inhibitors (PDE5Is) and Risk of Melanoma
Loeb, S., Ventimiglia, E., Salonia, A., Folkvaljon, Y., & Stattin, P. E. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx086 · Cited by 33
Interaction of molecular alterations with immune response in melanoma
Sloane, R. A. S., Gopalakrishnan, V., Reddy, S. M., Zhang, X., Reuben, A., & Wargo, J. A. (2017) · Cancer · doi:10.1002/cncr.30681 · Cited by 33
Fecker, L. F., Eberle, J., Orfanos, C. E., & Geilen, C. C. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01744.x · Cited by 32
Mourah, S., Denis, M. G., Escande, F., Solassol, J., Merlin, J., Sabourin, J., Scoazec, J., Ouafik, L., Emile, J., Heller, R., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120232 · Cited by 32
Grammatico, P., Maresca, V., Roccella, F., Roccella, M., Biondo, L., Catricalà, C., & Picardo, M. (1998) · Experimental Dermatology · doi:10.1111/j.1600-0625.1998.tb00325.x · Cited by 32
Prasad, R., Kappes, J. C., & Katiyar, S. K. (2016) · Oncotarget · doi:10.18632/oncotarget.6860 · Cited by 32
Cited by
Biomarkers, oxidative stress and autophagy in skin aging
Gu, Y., Han, J., Jiang, C., & Zhang, Y. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101036 · Cited by 762
Focus on the Contribution of Oxidative Stress in Skin Aging
Papaccio, F., D′Arino, A., Caputo, S., & Bellei, B. (2022) · Antioxidants · doi:10.3390/antiox11061121 · Cited by 396
Oxidative Stress-Related Mechanisms in Melanoma and in the Acquired Resistance to Targeted Therapies
Pizzimenti, S., Ribero, S., Cucci, M. A., Grattarola, M., Monge, C., Dianzani, C., Barrera, G., & Muzio, G. (2021) · Antioxidants · doi:10.3390/antiox10121942 · Cited by 79
Upadhyay, P. R., Starner, R. J., Swope, V. B., Wakamatsu, K., Ito, S., & Abdel-Malek, Z. A. (2022) · Antioxidants · doi:10.3390/antiox11061204 · Cited by 30
Metadata
- Authors
- Obrador, E., Liu-Smith, F., Dellinger, R. W., Salvador, R., Meyskens, F. L., & Estrela, J. M.
- Affiliations
- Universitat de València (ES)
- Department of Epdemiology, Department of Medicine , Chao Family Comprehensive Cancer Center, University of California Irvine , Irvine, CA 92697 , USA
- Elysium Health, Inc. (United States) (US)
- Department of Phisiology , University of Valencia , 46010 Valencia , Spain
- University of California, Irvine (US)
- Corresponding author
- Estrela, José M.
- Venue
- Biological Chemistry
- Publisher
- Walter de Gruyter GmbH
- Published
- 2018-10-31
- Volume
- 400
- Issue
- 5
- Pages
- 589-612
- ISSN
- 1431-6730 (ISSN-L)
- 1437-4315
- OpenAlex
- W2896725329
- Cited by
- 119
- References
- 233
- Citations by year
- 2026: 2 · 2025: 10 · 2024: 23 · 2023: 23 · 2022: 26 · 2021: 15 · 2020: 17 · 2019: 3
- FWCI
- 0.86
- Type
- journal article
- Language
- en
- Open access
- green
- escholarship.org
- Licence
- cc-by
- Locations
- Biological Chemistry (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Repository of Digital Objects for Teaching Research and Culture (University of Valencia) (submittedVersion, cc-by-nc)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Keywords
- melanoma, oxidative stress, antioxidants, redox signaling, reactive oxygen species, reactive nitrogen species, melanin, ultraviolet radiation, drug resistance, metastasis, apoptosis
- MeSH terms
- Animals, Antioxidants, Humans, Melanoma, Oxidation-Reduction, Signal Transduction, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.